RETRACTED ARTICLE: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours

F Xu, L Na, Y Li, L Chen - Cell & bioscience, 2020 - Springer
Abstract The PI3 K/AKT/mTOR signalling pathway plays an important role in the regulation of
signal transduction and biological processes such as cell proliferation, apoptosis …

Synaptic basis of Alzheimer's disease: Focus on synaptic amyloid beta, P-tau and mitochondria

A John, PH Reddy - Ageing research reviews, 2021 - Elsevier
Alzheimer's disease (AD) is a progressive and synaptic failure disease. Despite the many
years of research, AD still harbors many secrets. As more of the world's population grows …

New insights into drug discovery targeting tau protein

Y Soeda, A Takashima - Frontiers in molecular neuroscience, 2020 - frontiersin.org
Microtubule-associated protein tau is characterized by the fact that it is an intrinsically
disordered protein due to its lack of a stable conformation and high flexibility. Intracellular …

Tau phosphorylation: the therapeutic challenge for neurodegenerative disease

DP Hanger, BH Anderton, W Noble - Trends in molecular medicine, 2009 - cell.com
The microtubule-associated protein tau is integral to the pathogenesis of Alzheimer's
disease (AD), as well as several related disorders, termed tauopathies, in which tau is …

Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease

CX Gong, K Iqbal - Current medicinal chemistry, 2008 - ingentaconnect.com
Alzheimer disease (AD) is the most common cause of dementia in adults. The current
therapy for AD has only moderate efficacy in controlling symptoms, and it does not cure the …

Alzheimer's disease as homeostatic responses to age-related myelin breakdown

G Bartzokis - Neurobiology of aging, 2011 - Elsevier
The amyloid hypothesis (AH) of Alzheimer's disease (AD) posits that the fundamental cause
of AD is the accumulation of the peptide amyloid beta (Aβ) in the brain. This hypothesis has …

Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies

KR Brunden, JQ Trojanowski, VMY Lee - Nature reviews Drug …, 2009 - nature.com
Neuronal inclusions comprised of the microtubule-associated protein tau are found in
numerous neurodegenerative diseases, commonly known as tauopathies. In Alzheimer's …

Protein phosphorylation in neurodegeneration: friend or foe?

S Tenreiro, K Eckermann, TF Outeiro - Frontiers in molecular …, 2014 - frontiersin.org
Protein misfolding and aggregation is a common hallmark in neurodegenerative disorders,
including Alzheimer's disease (AD), Parkinson's disease (PD), and fronto-temporal dementia …

Mechanisms of melatonin in alleviating Alzheimer's disease

M Shukla, P Govitrapong, P Boontem… - Current …, 2017 - ingentaconnect.com
Alzheimer's disease (AD) is a chronic, progressive and prevalent neurodegenerative
disease characterized by the loss of higher cognitive functions and an associated loss of …

Physiological and pathological phosphorylation of tau by Cdk5

T Kimura, K Ishiguro, S Hisanaga - Frontiers in molecular …, 2014 - frontiersin.org
Hyperphosphorylation of microtubule-associated protein tau is one of the major pathological
events in Alzheimer's disease (AD) and other related neurodegenerative diseases, including …